Cipla EU divests stake in Chase Pharmaceuticals to Allergan

Cipla announces Q2 FY17 results - Improved profitability in base business & Strengthened R&D pipeline

Cipla Receives EIR from the US FDA for its Indore facility

Cipla Receives Final Approval for Generic Enablex® Tablets

Cipla Receives Final Approval for Generic Wellbutrin XL® Tablets

Cipla announces Q1 FY17 results Performance reflects continued momentum in key markets and improvement in base EBITDA margins

Cipla names Umang Vohra as MD & Global CEO; Samina Vaziralli is Executive Vice-Chairman

Cipla joins global movement to eliminate viral hepatitis by 2030

Cipla to launch South Africa’s first Biotech manufacturing facility

Nacimbio launches complex programme for antiretroviral drugs production